Credence Research Inc. has released a new study on the Blood Glucose Monitoring Devices Market. According the report the ...
New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
4don MSN
Dexcom outlines 2026 revenue growth of 11%-13% with G7 15 day rollout and international expansion
Q4 2025 Management View Jacob Leach, President, CEO & Director, marked his first call as CEO by outlining three strategic priorities: "We will be the premier glucose sensing solution for all," ...
Q4 2025 Earnings Call February 12, 2026 4:30 PM ESTCompany ParticipantsSean Christensen - Vice President of Finance and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results